Trial Details

Not Recruiting
Basic Information
Clinical ID c5624
Identifier NL-OMON45538
Trial Title A first-in-human, randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study to investigate the safety, tolerability, pharmacokinetics (including food effect), pharmacodynamics and proof of concept of CKD-506 in
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions inflammatory bowel disease rheumatoid arthritis;10017969;10023213;inflammatory bowel disease;rheumatoid arthritis
Interventions Groups 1, 2, 3, 4 (only the first period), 5 and 6:The SAD part of the study will consist of 1 study period (except for Group 4, see below) during which you will receive either CKD-506 or placebo once under fasted conditions. CKD-506 and pl
Participant Information
Sponsor Chong Kun Dang Pharmaceutical Corp.
City NULL
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement ADULT
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL